Molecular characterization of metastatic colorectal cancer (mCRC) in patients (pts) treated with cetuximab and pembrolizumab.

被引：0
|
作者：
Fountzilas, Christos
Rosario, Spencer
Withers, Henry G.
Mukherjee, Sarbajit
Bajor, David L.
Saltzman, Joel N.
Wang, Chong
Attwood, Kristopher
Knudsen, Erik S.
Witkiewicz, Agnieszka K.
Iyer, Renuka V.
Boland, Patrick M.
机构：
[1] Roswell Pk Comprehens Canc Ctr, Div GI Med, Dept Med, Buffalo, NY USA
[2] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
[3] Case Western Reserve Univ, Case Comprehens Canc Ctr, Univ Hosp, Seidman Canc Ctr, Cleveland, OH USA
[4] Cleveland Clin, Cleveland, OH USA
[5] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
178
引用
收藏
页码：178 / 178
页数：1
相关论文
共 50 条
  • [1] Cetuximab (Cet) clearance and survival in patients (pts) with metastatic colorectal cancer (mCRC)
    Jiang, Di Maria
    Sim, Hao-Wen
    Siu, Lillian L.
    Shapiro, Jeremy David
    Liu, Geoffrey
    Price, Timothy Jay
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [2] Cetuximab (Cet) clearance and survival in patients (pts) with metastatic colorectal cancer (mCRC).
    Jiang, Di Maria
    Sim, Hao-Wen
    Siu, Lillian L.
    Shapiro, Jeremy David
    Liu, Geoffrey
    Price, Timothy Jay
    Jonker, Derek J.
    Karapetis, Christos Stelios
    Strickland, Andrew
    Zhang, Wenjiang
    Jeffery, Mark
    Tu, Dongsheng
    Ng, Siobhan
    Sabesan, Sabe S.
    Shannon, Jenny
    Townsend, Amanda Rose
    Morgen, Eric
    Xu, Wei
    O'Callaghan, Christopher J.
    Chen, Eric Xueyu
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Clinical outcome of patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) treated with pembrolizumab.
    Sinicrope, Frank A.
    Chakrabarti, Sakti
    Eiring, Rachel
    Mitchelll, Jessica L.
    Finnes, Heidi D.
    Hubbard, Joleen Marie
    McWilliams, Robert R.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Skin toxicity in elderly patients with metastatic colorectal cancer (mCRC) treated with Cetuximab
    Jehn, C.
    Stenzel, L.
    Boening, L.
    Kroening, H.
    Possinger, K.
    Lueftner, D.
    ONKOLOGIE, 2010, 33 : 175 - 176
  • [5] Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib
    Schirripa, M.
    Loupakis, F.
    Cremolini, C.
    Poliseno, L.
    Salvatore, L.
    Tuccoli, A.
    Antoniotti, C.
    D'Aurzio, R.
    Marmorino, F.
    Borelli, B.
    Rossini, D.
    Saettini, A.
    Gini, S.
    Moretto, R.
    Rizzo, I.
    Aquila, E. Dell'
    Pellegrini, M.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2015, 26
  • [6] Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib
    Antoniotti, C.
    Loupakis, F.
    Schirripa, M.
    Cremolini, C.
    Poliseno, L.
    Salvatore, L.
    Tuccoli, A.
    D'Aurizio, R.
    Marmorino, F.
    Borelli, B.
    Rossini, D.
    Saettini, A.
    Gini, S.
    Moretto, R.
    Rizzo, I.
    Dell'Aquila, E.
    Pellegrini, M.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2015, 26 : 37 - 38
  • [7] Institutional experiences with panitumumab monotherapy in metastatic colorectal cancer (mCRC) patients (pts) intolerant to cetuximab
    Langerak, A. D.
    Mitchell, E.
    Cheema, P.
    River, G. L.
    Shing, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Initial correlative studies from a trial of cetuximab and pembrolizumab in metastatic colorectal cancer (mCRC).
    Boland, Patrick M.
    Muhitch, Jason
    Abrams, Scott, I
    Maguire, Orla
    Minderman, Hans
    Bajor, David Lawrence
    Saltzman, Joel N.
    Wang, Katy
    Hutson, Alan
    Mukherjee, Sarbajit
    Iyer, Renuka, V
    Kalinski, Pawel
    Fountzilas, Christos
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Phase Ib/II study of ibrutinib (ibr) in combination with cetuximab (cetux) in patients (pts) with previously treated metastatic colorectal cancer (mCRC)
    Oh, D-Y.
    Arkenau, T.
    Lee, K-W.
    Alsina, M.
    Marti, F. M.
    Chung, I. J.
    Saif, W.
    Wang, D.
    O'Dwyer, P.
    Chau, I.
    Lee, M-A.
    Chong, E.
    Hilger-Rolfe, J.
    Cole, G., Jr.
    Kim, S. Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S428 - S428
  • [10] Irinotecan (Iri) and buparlisib (B) in previously treated patients (pts) with metastatic colorectal cancer (mCRC).
    Baranda, Joaquina Celebre
    Reed, Greg
    Williamson, Stephen K.
    Perez, Raymond P.
    Stoltz, Maxine L.
    Mackay, Chris
    Madan, Rashna
    Pessetto, Ziyan Y.
    Godwin, Andrew K.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
12345